Space Travel News  
EPIDEMICS
Philippines, Cambodia, Serbia in line for China's Covid-19 vaccines
by AFP Staff Writers
Manila (AFP) Jan 16, 2021

Beijing's top diplomat pledged Saturday to donate half a million coronavirus vaccine shots to the Philippines, Manila officials said -- despite growing resistance there to Chinese-made jabs over concerns about their efficacy.

President Rodrigo Duterte's administration is scrambling to lock in supplies of Covid-19 vaccines for the country's 110 million people, after being criticised for being too slow off the mark in the global race to procure the drugs.

Among other deals, the Philippines has already agreed to buy 25 million doses of Chinese company Sinovac's Coronavac, despite the jab not having been approved by regulators in China.

It is not clear which vaccine China will donate, and whether the donation is part of that earlier deal; the Chinese embassy in Manila did not respond to AFP's request for comment.

China's Foreign Minister Wang Yi told his counterpart of the intended donation when he was in Manila on Saturday, the Philippines foreign ministry said.

The news follows similar announcements from other countries in the region earlier this week - Cambodia said it would receive one million free doses from Beijing on Friday, after Myanmar was set to get 300,000.

Duterte has actively sought closer ties with Beijing since taking power in 2016, and has defended Chinese vaccines in the face of widespread misgivings over their effectiveness.

Although trials in Turkey found Coronavac to be 91.25 percent effective, other, more robust trials in Brazil only demonstrated an efficacy rate of around 50 percent.

Duterte came under fire last month after he revealed that members of his security team had been given a jab made by another Chinese company, Sinopharm, even though it had not been approved for use.

Nearly half a million people have been infected with the virus in the Philippines, with almost 10,000 fatalities.

Health officials have warned of a possible spike in cases following the Christmas holidays, religious parades and a confirmed case of the more infectious strain first identified in Britain.

Serbia gets Chinese-made Sinopharm jabs
Belgrade (AFP) Jan 16, 2021 - Serbia became one of the first European countries to receive a Chinese-made Covid-19 vaccine on Saturday when one million doses of a jab produced by Sinopharm arrived at Belgrade airport.

President Aleksandar Vucic posted a picture of himself on Instagram, standing next to the plane carrying the vaccine.

"We are proud of our friendship with China," he was quoted as saying by Beta news agency, telling reporters that he hoped to be inoculated with the Sinopharm vaccine in six or seven days.

After Pfizer-BioNTech and Russia's Sputnik V, Sinopharm's is the third coronavirus vaccine to be used by the Balkan nation.

Once the Chinese vaccine gets a final approval by Serbia's medicines agency, vaccination could start on Sunday or Monday, health official Zoran Gojkovic said earlier.

The European Union-candidate country, which has also close economic and political ties with Moscow and Beijing, started vaccination with Pfizer-BioNTech jabs on December 24 and later imported Russian Sputnik V vaccines.

Sinopharm says its vaccine is 79 percent effective against the novel coronavirus, compared with rates of 95 percent and 94 percent respectively for the rival jabs made by Pfizer-BioNTech and Moderna.

Another Chinese-made jab, Sinovac's CoronaVac, was rolled out in Turkey on Thursday, after tests there showed it to be 91.25 percent effective.

But more robust trials in Brazil demonstrated an efficacy rate of around 50 percent.

So far, some 20,500 people -- residents of retirement homes and health sector employees -- have been vaccinated in Serbia, a country with a population of seven million, the national immunisation team said Friday.

Serbia has registered nearly 370,000 infections and more than 3,700 deaths from the novel coronavirus.

'Friend' China to donate one million vaccine doses to Cambodia: PM
Phnom Penh (AFP) Jan 16, 2021 - China will donate one million doses of its Sinovac coronavirus vaccine to Cambodia, the kingdom's strongman premier Hun Sen has said, thanking "friend" Beijing for its generosity.

Cambodia has long been a staunch ally of Beijing, receiving billions of dollars in soft loans and investment from China.

While many countries reacted early in the pandemic by closing its borders to Chinese travellers, Hun Sen refused, and even travelled to Beijing to meet with leader Xi Jinping in a show of solidarity.

The premier announced late Friday that China has offered to donate shots made by the firm Sinovac.

"Friend China is helping us with one million doses," Hun Sun said in an audio message on his official Facebook page, adding that the doses will vaccinate 500,000 people.

"To prevent the nation and people from being infected with this deadly virus, we have to use vaccines that were already used on Chinese leaders and millions of people... We cannot wait any longer."

The first people to get the jab would include frontline health workers, teachers, soldiers, the premier's bodyguards, and officials around the king, he said.

Sinovac's CoronaVac was rolled out in Turkey on Friday, after tests there showed it to be 91.25 percent effective.

But more robust trials in Brazil demonstrated an efficacy rate of around 50 percent -- much lower than those of rival shots from Moderna, Pfizer-BioNTech and Oxford-AstraZeneca.

A third trial in Indonesia -- where authorities this week kicked off a mass vaccination drive with CoronaVac shots -- showed an efficacy of 65.3 percent.

Cambodia has appeared to do well in the pandemic so far, registering just 436 cases, though experts say the low numbers are likely due to a lack of testing.

Beijing has also offered to help another nation in the region, with Chinese Foreign Minister Wang Yi promising this week to provide 300,000 doses to Myanmar.


Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only


EPIDEMICS
Turkey approves China's Sinovac jab, Senegal in talks buy Sinopharm vaccine
Ankara (AFP) Jan 13, 2021
Turkey on Wednesday approved the emergency use of a coronavirus jab developed by China's Sinovac, paving the way for a national vaccination drive that will start with healthcare workers. Health Minister Fahrettin Koca rolled up his sleeve and received the first shot of CoronaVac after announcing plans to start administering it nationally on Thursday. "Everyone should get vaccinated because it is the only way to get rid of this pandemic," Koca said in televised comments. Turkey said last mont ... read more

Comment using your Disqus, Facebook, Google or Twitter login.



Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

EPIDEMICS
EPIDEMICS
Frosty scenes in martian summer

Seven things to know about the NASA rover about to land on Mars

China Focus: 400 mln km within 163 days, China's Mars probe heads for red planet

Tianwen 1 robotic probe to enter Mars orbit in Feb

EPIDEMICS
Tiny NASA cameras to watch commercial lander form craters on moon

Chang'e 4 probe resumes work for 26th lunar day

UK eyes plan to send first rover to Moon in 2021

Lunar gold rush could create conflict on the ground if we don't act now

EPIDEMICS
Dark Storm on Neptune reverses direction, possibly shedding a fragment

The 'Great' Conjunction of Jupiter and Saturn

NASA's Juno Spacecraft Updates Quarter-Century Jupiter Mystery

Swedish space instrument participates in the search for life around Jupiter

EPIDEMICS
A rocky planet around one of our galaxy's oldest stars

Astronomers find evidence for planets shrinking over billions of years

Astronomers measure enormous planet lurking far from its star

Discovery boosts theory that life on Earth arose from RNA-DNA mix

EPIDEMICS
Rolls-Royce and UK Space Agency launch study into nuclear-powered space exploration

SpaceX Dragon capsule to make first of its kind science splashdown

Flexibility and resiliency define Arianespace's performance in 2020

SpaceX launches Turkish satellite from Florida

EPIDEMICS
Chinese space enterprise gears up for record-breaking 40-plus launches in 2021

China's space achievements out of this world

China's Chang'e-5 orbiter embarks on new mission to gravitationally stable spot at L1

China plans to launch four manned spacecraft in next two years

EPIDEMICS
Remote sensing data sheds light on when and how asteroid Ryugu lost its water

NASA's first mission to the Trojan Asteroids integrates its second scientific instrument

Knowledge of asteroid composition to help avert collisions

EMXYS and Royal Observatory, Belgium to participate in planetary defence Hera space mission









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.